Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non–small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study

Andrea Luciani, Antonio Marra, Luca Toschi, Diego Cortinovis, Sergio Fava, V. Filipazzi, Alessandro Tuzi, Giulio Cerea, Sabrina Rossi, Vittorio Perfetti, Antônio Rossi, Laura Giannetta, Luca Sala, Giovanna Finocchiaro, Elio Gregory Pizzutilo, Stephana Carelli, Francesco Agustoni, Massimiliano Cergnul, S. Zonato, Salvatore Siena, Paolo Bidoli, Daris Ferrari